VAUDREUIL-DORION, QUEBEC -- (Marketwire) -- 02/07/13 -- Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Company"), today released its Year End 2012 financial results for the period ended October 31, 2012.

"Over the last twelve months, our Company has recruited 43,000 new distributors, a 41% increase over the prior year. This strong recruitment performance has improved our profitability and strengthens our balance sheet", said Bob Henry, Immunotec's Chairman and CEO. "Our product line is creating significant opportunities for distributors and we are as confident as ever in the future of Immunotec."

Highlights for the year

-- Total Revenue reached $49.2M, an increase of 15% as compared to the
previous year.
-- Network sales reached $44.2M, an increase of 18% as compared to the same
period in the previous year.
-- Selected expenses(1), defined as administrative, marketing and selling,
quality and development expenses amounted to $11.9M and measured
favorably, as a percentage of total revenues by improving to 24% as
compared to 28% of total revenues last year.
-- Adjusted EBITDA(1) improved to $1.9M or 3.8% of total revenues, compared
to $0.6M or 1.4% of total revenues over last year, a major improvement.
-- Net profit of $125 thousand, a significant improvement over last year
(net loss of $1.4M).

(1) Refers to adjusted EBITDA in non-GAAP financial measures section of the Management Discussion and Analysis.

Modifications to the Corporation's Stock Option Plan

The Board of Directors has also approved a modification to the Company's Stock Option Plan, whereby it removed the 2-month hold period which applied to shares issued following the exercise of options under such Plan.

About Immunotec Inc.

Immunotec is a world class business opportunity supported by unique scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Company also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Europe, Mexico and the Caribbean.

The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Trust is the fundamental building block of any relationship. Whether it's personal or business, trust is something that cannot be replaced with anything. There are hundreds of books available on how to cultivate business relationships, how to maintain them, and how to leverage the best...

It’s easy to fall into a pattern of dysfunctional releases, release processes that are characterized by delay, inefficiency, and endless meetings that encourage people to view releases as a problem. These are the kinds of meetings that inspire references to the movie Office Space or em...

Log data provides the most granular view into what is happening across your systems, applications, and end users. Logs can show you where the issues are in real-time, and provide a historical trending view over time. Logs give you the whole picture.
Logstash is an open source tool fo...

Over on the other side of the fence IT ops are screaming at the various portfolio dev teams for releasing highly risky functionality way too frequently but since the Agile dev adoption production has only had a couple of low priority P4 incidents caused by bad code releases. Things mus...

Application experience aficionados take note: you have choices now. No longer are you constrained to just HTTP/1 with a side option of WebSockets or SPDY. HTTP/2 is also an option, one that like its SPDY...